Abstract
Background
Recurrence after curative hepatectomy for colorectal liver metastases (CRLM) is common. We sought to determine if number and sites of resections of recurrence after hepatectomy for CRLM impact survival.
Methods
The study included patients who underwent resection of recurrence following complete curative-intent resection of CRLM during 1998–2016 at two academic medical centers in Houston, USA, and Rome, Italy. The survival impacts of number and sites of resections of recurrence were evaluated. Patients with synchronous extrahepatic disease at curative CRLM resection were excluded.
Results
Among 2163 patients who underwent curative hepatectomy, 1456 (67.3%) developed a recurrence. Four hundred seventy-eight patients underwent one (322/478; 67.4%) or two or more (156/478; 32.6%) resections of recurrence. The 5-year overall survival (OS) rate was higher in patients with resected than unresected recurrence (70.2% vs. 24.0%; p < 0.001). In patients who underwent only one resection of recurrence, the 5-year OS rate differed by location (lung, 81.6%; liver, 64.3%; other, 54.1%). In patients who underwent two or more resections of recurrence, the 5-year OS rate was similar for liver-only resection (87.5%) and resection of liver and other sites (66.1%) (p = 0.223) and for liver-only resection and other-sites-only resection (80.7%) (p = 0.258); 5-year OS rate by site of first resection of recurrence did not differ between liver (78.5%) and lung (81.8%) (p = 0.502) but was worse for other sites (61.1%) than for lung (p = 0.045).
Conclusion
When recurrence after initial CRLM resection is resectable, the ability to undergo resection was associated with improved survival and can be considered as an option regardless of the number of recurrence and resection. Sites of resection of recurrence impact survival and should be considered.
Similar content being viewed by others
References
de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, Chota MA, Aldrighetti L, Capussotti L, Pawlik TM. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 2009;250:440-448.
D’Angelica M, Kornprat P, Gonen M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases. Ann Surg Oncol 2011;18:1096-1103.
Beppu T, Sakamoto Y, Hasegawa K, Goro H, Kuniya T, Yoshihito K, Hiroyuki N, Hiroyuki Y, Etsuro H, Masaki U, Hiroyuki T, Hideo B, Tomoo K, Norihiro K, Keiichi T, Itaru E, Go W, Masaru M, Shinji U, Tetsuo O, Ken K, Hiroki Y, Masakazu Y, Tadahiro T. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2012;19:72-84.
Saiura A, Yamamoto J, Hasegawa K, Koga R, Sakamoto Y, Hata S, Makuuchi M, Kokudo N. Liver resection for multiple colorectal liver metastases with surgery up-front approach: bi-institutional analysis of 736 consecutive cases. World J Surg 2012;36:2171-2178.
Vauthey JN, Zimmitti G, Kopetz SE, Shindoh J, Chen SS, Andreou A, Curley SA, Aloia TA, Maru DM. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg 2013;258: 619-626.
Shindoh J, Nishioka Y, Yoshioka R, Sugawara T, Sakamoto Y, Hasegawa K, Masaji H, Kokudo N. KRAS mutation status predicts site-specific recurrence and survival after resection of colorectal liver metastases irrespective of location of the primary lesion. Ann Surg Oncol 2016;23:1890-1896.
Vaillant JC, Balladur P, Nordlinger B, Karaitianos I, Hannoun L, Huguet C, Parc R. Repeat liver resection for recurrent colorectal metastases. Br J Surg 1993;80:340-344.
Petrowski H, Gonen M, Jarnagin W, Lorenz M, DeMatteo R, Heinrich S, Encke A, Blumgart L, Fong Y. Second liver resection are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 2002;235: 863-871.
Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H. Liver resection for colorectal metastases. The third hepatectomy. Ann Surg 2003;238:871-884.
Kulik U, Bektas H, Klempnauer J, Lehner F. Repeat liver resection for colorectal metastases. Br J Surg 2013;100:926-932.
Andreou A, Brouquet A, Abdalla EK, Aloia TA, Curley SA, Vauthey JN. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford) 2011;13:774-782.
Butte JM, Gonen M, Allen PJ, Kingham TP, Sofocleous CT, DeMatteo RP, Fong Y, Kemeny NE, Jarnagin WR, D'Angelica MI. Recurrence after partial hepatectomy for metastatic colorectal cancer: potentially curative role of salvage repeat resection. Ann Surg Oncol 2015;22:2761-2771.
Sponholz S, Schirren M, Baldes N, Oguzhan S, Schirren J. Repeat resection for recurrent pulmonary metastasis of colorectal cancer. Langenbecks Arch Surg 2017;402:77-85.
Hishida T, Tsuboi M, Okumura T, Boku N, Ohde Y, Sakao Y, Yoshiya K, Hyodo I, Mori K, Kondo H.. Does repeated lung resection provide long-term survival for recurrent pulmonary metastases of colorectal cancer? Results of a retrospective Japanese multicenter study. Ann Thoracic Surg 2017;265:158-165.
Yang KM, Park IJ, Lee JL, et al. Benefits of repeated resections for liver and lung metastases from colorectal cancer. Asian J Surg 2020;43:102-109.
Nagakura S, Shirai Y, Suda T, et al. Multiple repeat resections of intrahepatic and extrahepatic recurrences in patients undergoing initial hepatectomy for colorectal carcinoma metastases. World J Surg 2002;26:141-147.
Oba M, Hasegawa K, Shindoh J, et al. Survival benefit of repeat resection of successive recurrences after the initial hepatic resection for colorectal liver metastases. Surgery 2016;159:632-640.
Imai K, Yamashita Y, Miyamoto Y, et al. The predictors and oncological outcomes of repeat surgery for recurrence after hepatectomy for colorectal liver metastases. Int J Clin Oncol 2018;23:908-916.
Adam R, De Gramont A, Figueras J, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 2012;17:1225-1239.
Viganò L, Costa G, Cimino MM, Procopio F, Donadon M, Del Fabbro F, Belghiti J, Kokudo N, Makuuchi M, Vauthey JN, Torzilli G. R1 resection for colorectal liver metastases: a survey questioning surgeons about its incidence, clinical impact, and management. J Gastrointest Surg 2018;22:1752-1763.
Imai K, Allard MA, Benitez CC, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Bismuth H, Baba H, Adam R. Early recurrence after hepatectomy for colorectal liver metastases: what optimal definition and what predictive factors? Oncologist 2016;21:887-894.
Matsumoto T, Hasegawa S, Hida K, Kawada K, Sakai Y, Sugihara K. Role of repeat resection in patients with metastatic colorectal cancer: a multicenter retrospective study. Dis Colon Rectum 2019;62:561-567.
Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Omichi K, Tzeng CD, Chun YS, Vauthey JN, Conrad C. RAS mutation is associated with unsalvageable recurrence following hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 2018; 25:2457-2466.
Acknowledgements
The authors thank Dr. Yujiro Nishioka and Dr. Francesco Razionale for reviewing the data used in the study, Ms. Stephanie Deming, Senior Scientific Editor at MD Anderson Cancer Center, for copyediting the manuscript, and Ms. Ruth Haynes for administrative support in the preparation of this article.
Author information
Authors and Affiliations
Contributions
EP contributed to the conception/design of the work; EP, YK, JV contributed to the acquisition, analysis, or interpretation of the data; EP and BK drafted the manuscript; all authors critically revised the manuscript for intellectual content; and all authors approved the final version submitted and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Meeting presentation: Oral presentation, 14th IHPBA World Congress. Virtual Congress, 27–29 November 2020.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Panettieri, E., Kim, B.J., Kawaguchi, Y. et al. Survival by Number and Sites of Resections of Recurrence after First Curative Resection of Colorectal Liver Metastases. J Gastrointest Surg 26, 2503–2511 (2022). https://doi.org/10.1007/s11605-022-05456-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-022-05456-0